Clinical trial Recruiting at 1 site Observational Ages 18 to 80 Men only

Evaluating hormone levels in obese men

Official title: Studio Del Milieu Steroideo in Pazienti Obesi

Run by Istituto Auxologico Italiano · NCT06341699 · Data updated 2026-11-12

This study is testing how hormone levels in obese men affect their bone health and heart disease risk.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexMen only
Enrollment180 (estimated)
SponsorIstituto Auxologico Italiano
Academic / other
Locations1 site (Oggebbio, Verbania)
StatusRecruiting
StartedMay 16, 2023
Main results expectedJune 30, 2026
Study endsJune 30, 2026
Registry record updatedMay 13, 2025
Trial IDNCT06341699 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are male patients aged 18-80 years with severe obesity and no other known causes of hormonal imbalances.

Probably not a fit

Patients with severe systemic diseases, those using corticosteroids, or individuals with specific hormonal pathologies will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess cortisol and testosterone secretion in obese male patients, along with their receptor sensitivity to these hormones. The research will explore the relationship between these hormonal levels and their impact on bone metabolism, lipoprotein function, and the severity of obesity-related complications. Additionally, the study will investigate whether these hormonal factors can predict cardiovascular disease in this population. Data will be collected through questionnaires and blood tests, with analysis conducted at a centralized laboratory.

Why it matters

Potential benefit: If successful, this study could provide insights into hormonal influences on obesity and related health risks, potentially guiding future treatments.

How similar studies have gone: While there have been studies on hormonal influences in obesity, this specific approach focusing on the interplay of cortisol and testosterone in morbidly obese men is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* morbid obesity

Exclusion Criteria:

* patients suffering from severe systemic pathologies, fever, chronic inflammatory states known to cause PCR \>10 mg/dL
* use of corticosteroids at the time of enrollment
* the patient's poor understanding of spoken and written Italian
* patients suffering from primary pathologies of the testicle, known at enrollment
* patients suffering from hypothalamic-pituitary or adrenal pathologies already known at the time of enrollment

Where it's running

  • Istituto Auxlogico Italiano, Hospital San Giuseppe, Piancavallo
    Oggebbio, Verbania, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.